SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Omeros Corp. operates as a biopharmaceutical company. The firm engages in the discovery, development, and commercializing of both small-molecule and protein therapeutics for large market. It also offers orphan indications targeting inflammation, coagulopathies, and disorders of the central nervous system. The company was founded by Gregory A. Demopulos and Pamela Pierce Palmer on June 16, 1994 and is headquartered in Seattle, WA.

Omeros Corporation

Omeros Corp

Omeros Corp is seeing a significant surge in trading volume and price following the FDA approval of Yartemlea, its first-in-class therapy for a severe transplant-associated complication. The community is actively debating the stock's substantial undervaluation, fueled by its pipeline validation, a major licensing deal with Novo Nordisk, and potential for a short squeeze. Many foresee considerable upside, with discussions circling around valuations far exceeding current levels, while some also acknowledge concerns about possible dilution.

The Cosmos network consists of many independent, parallel blockchains, called zones, each powered by classical Byzantine fault-tolerant (BFT) consensus protocols like Tendermint. Some zones act as hubs with respect to other zones, allowing many zones to interoperate through a shared hub. The architecture uses classic BFT and Proof-of-Stake algorithms, instead of Proof-of-Work. Cosmos can interoperate with multiple other applications and cryptocurrencies, something other blockchains can’t do well. By creating a new zone, you can plug any blockchain system into the Cosmos hub and pass tokens back and forth between those zones, without the need for an intermediary.  While the Cosmos Hub is a multi-asset distributed ledger, there is a special native token called the atom. ATOM have three use cases: as a spam-prevention mechanism, as staking tokens, and as a voting mechanism in governance.  As a spam prevention mechanism, ATOM are used to pay fees. The fee may be proportional to the amount of computation required by the transaction, similar to Ethereum’s concept of “gas”. Fee distribution is done in-protocol and a protocol specification is described here.  As staking tokens, ATOM can be “bonded” in order to earn block rewards. The economic security of the Cosmos Hub is a function of the amount of ATOM staked. The more ATOM that are collateralized, the more “skin” there is at stake and the higher the cost of attacking the network. Thus, the more ATOM there are bonded, the greater the economic security of the network.  Atom holders may govern the Cosmos Hub by voting on proposals with their staked ATOM.

Cosmos

Cosmos (ATOM) is trending as its community actively works on a significant tokenomics redesign to shift from inflationary rewards to a revenue-based model, aiming to enhance value accrual and mitigate sell pressure. This move is a major talking point, with some users hopeful for long-term growth given ATOM's foundational role in interoperability and ecosystem expansion. However, others remain critical of its recent price action despite attractive staking yields, leading to an active debate about ATOM's future utility within the evolving blockchain landscape.

Dynavax Technologies Corp. is a biopharmaceutical company, which engages in the provision of discovery, development, and commercialization of novel vaccines and immuno-oncology therapeutics. Its product includes HEPLISAV-B, which prevents infection caused by all known subtypes of hepatitis B virus in adults 18 years of age and older. The company was founded by Lawrence M. Lichtenstein, Dennis A. Carson, and Eyal Raz on August 29, 1996 and is headquartered in Emeryville, CA.

Dynavax Technologies Corp.

Dynavax is trending significantly following the announcement that Sanofi is acquiring the company for $15.50 per share, a move set to enhance Sanofi's adult immunization portfolio with Dynavax's key vaccine assets. The community is buzzing with discussions about the offer's fairness, with many long-term shareholders expressing frustration over the valuation compared to the stock's historical performance, while others celebrate the substantial immediate gains. This development underscores the continued strategic consolidations within the biotech vaccine sector.

Citigroup, Inc. is a holding company, which engages in the provision of financial products and services. It operates through the following segments: Services, Markets, Banking, Wealth, U.S. Personal Banking (USPB), and All Other. The Services segment includes Treasury and Trade Solutions (TTS) which provides an integrated suite of tailored cash management, trade, and working capital solutions to multinational corporations, financial institutions and public sector organizations, and Securities Services, which offers cross-border support for clients, providing on-the-ground local market expertise, post-trade technologies, customized data solutions, and a wide range of securities services solutions that can be tailored to meet client needs. The Markets segment provides corporate, institutional, and public sector clients around the world with a full range of sales and trading services across equities, foreign exchange, rates, spread products, and commodities. The Banking segment offers Investment Banking and Corporate Lending services. The Wealth segment includes Private Bank, Wealth at Work, and Citigold and provides financial services to a range of client segments through banking, lending, mortgages, investment, custody, and trust product offerings. The USPB segment includes Branded Cards and Retail Services, which have proprietary card portfolios and co-branded card portfolios within Branded Cards, and co-brand and private label relationships within Retail Services. The All Other segment consists of activities not assigned to the reportable operating segments, including certain unallocated costs of global functions, other corporate expenses, and net treasury results. The company was founded in 1812 and is headquartered in New York, NY.

Citigroup Inc

Citigroup is trending higher following significant regulatory relief, including the OCC removing a consent order and the Fed closing a supervisory notice, alongside strong earnings that underscore its ongoing transformation. The community is actively discussing its impressive multi-year rally, driven by broader financial sector optimism and ongoing corporate buybacks, though some express caution regarding its overbought technical conditions.

MiMedx Group, Inc. is a therapeutic biologics company, which engages in the design, manufacture, and marketing of products, and tissue processing services. It serves the wound care, burn, surgical, orthopedic, spine, sports medicine, ophthalmic, and dental sectors of healthcare. Its biomaterial platform technologies include AmnioFix and EpiFix, a tissue allografts derived from amnion and chorion layers of human placental membrane, EpiCord and AmnioCord, a tissue allografts derived from umbilical cord tissue, and AmnioFill, a placental connective tissue matrix derived from the placental disc and other placental tissue. The company was founded on July 30, 1985 and is headquartered in Marietta, GA.

Mimedx Group Inc

MiMedx Group is trending as recent CMS policy changes are poised to dramatically reshape the advanced wound care market by curbing fraud and prioritizing products with strong clinical evidence. The community is actively debating how these regulations will eliminate many higher-priced competitors, creating a significant market share opportunity for MDXG's proven offerings. Investors are keenly focused on how this shift towards evidence-based reimbursement could drive the company's long-term growth despite initial pricing adjustments.

RAWW MILK COIN

RAWW MILK COIN is buzzing as its community highlights a year of sustained development and continuous content drops, from new webtoons and "Truth Series" videos to an album and game updates. The sentiment centers on RAWW building a unique "anti-degen" lifestyle and expanding into a full cultural universe, rather than just being a typical meme coin. This consistent delivery, even through market volatility, underscores its distinct philosophy and community-driven longevity.

snowball is the first token in the world that uses the pumpfun creator fees to automatically marketmake itself aggressively.

snowball

SNOWBALL CRYPTO is trending as a new Solana-based project, with the community actively discussing its potential as a "scam dev detector" aimed at preventing "rug pulls." Many believe this innovative utility could be a "game changer" for new crypto launches, driving significant interest despite some caution among users regarding its rapid ascent.

Ethereum Classic

Ethereum Classic is trending prominently, fueling a polarized discussion within the crypto community. While many investors voice frustration over its prolonged underperformance relative to major cryptocurrencies, a strong cohort sees current valuations as a significant buying opportunity. This dedicated group anticipates ETC is poised for a substantial catch-up surge as the broader altcoin market evolves.

The KARRAT protocol is a decentralized gaming infrastructure layer, supported by $KARRAT and empowered by a truly decentralized community with a shared vision embracing gaming, entertainment and AI products catering for the new era.  To accelerate the evolution of gaming, entertainment, and AI-driven experiences with blockchain technology and a truly empowered community.  The KARRAT protocol pioneers a decentralized framework in gaming and entertainment, combining blockchain with community-driven collaboration. $KARRAT can animate ecosystems of games and products and the protocol makes tools available to support these industries and the adoption of KARRAT technology provides a unique, personalized gaming experience.

KARRAT

KARRAT CRYPTO is trending with significant community engagement around its potential in Web3 gaming and AI entertainment, driven by partnerships with Animoca Brands and whispers of collaborations with tech giants. Many enthusiasts view it as an undervalued, low-supply asset on the cusp of a major rally, likening its potential trajectory to other high-demand, limited-supply assets. Conversely, a vocal segment expresses strong concerns regarding ongoing token unlocks and perceived dilution, raising questions about the project's long-term viability.

NEAR Protocol is the blockchain for AI. A high-performance, AI-native platform built to power the next generation of decentralized applications and intelligent agents. It provides the infrastructure AI needs to transact, operate, and interact across Web2 and Web3. NEAR combines three core elements: User-Owned AI, which ensures agents act in users’ best interests; Intents and Chain Abstraction, which eliminate blockchain complexity for seamless, goal-driven transactions across chains; and a sharded blockchain architecture that delivers the scalability, speed, and low-cost execution needed for real-world AI and Web3 use. This integrated stack makes NEAR the foundation for building secure, user-owned, AI-native applications at internet scale.

Near

NEAR Protocol is trending due to its recent inflation rate cut and explosive growth in cross-chain transaction volume via NEAR Intents, signaling enhanced scarcity and utility. The community is actively discussing its leadership in AI integration and user-friendly experience, with many accumulating positions despite broader altcoin market weakness. This is further supported by significant institutional interest, positioning NEAR as a key player for future decentralized and AI-powered applications.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Acacia Research (NASDAQ:ACTG) Shares Pass Above 200 Day Moving Average - What's Next?

Acacia Research (NASDAQ:ACTG) Share Price Crosses Above 200-Day Moving Average - What's Next...

Corsair Capital Management L.P. Acquires New Stake in Acacia Research Corporation $ACTG

Corsair Capital Management L.P. acquired a new position in shares of Acacia Research Corporation (NASDAQ:ACTG - Free Report) in the 2nd quarter, according to the company in its most recent Form 13F...

Acacia Research Corporation to Present and Host 1x1 Investor Meetings at the 17th Annual Southwest IDEAS Investor Conference on November 20th in Dallas, TX

Acacia Research Corporation (Nasdaq: ACTG) (Acacia or the Company), which acquires and operates businesses across the industrial, energy and technology sectors, today announced that members of...

Wall Street Zen Upgrades Acacia Research (NASDAQ:ACTG) to "Buy"

Wall Street Zen upgraded shares of Acacia Research from a "hold" rating to a "buy" rating in a report on Saturday...

Acacia Research (NASDAQ:ACTG) Stock Passes Above 200-Day Moving Average - Time to Sell?

Acacia Research (NASDAQ:ACTG) Share Price Passes Above 200 Day Moving Average - Here's Why...

Acacia Research (NASDAQ:ACTG) Announces Earnings Results, Beats Expectations By $0.11 EPS

Acacia Research (NASDAQ:ACTG - Get Free Report) released its earnings results on Wednesday. The business services provider reported ($0.03) earnings per share for the quarter, topping analysts...

Acacia Research Corporation Reports Third Quarter 2025 Financial Results

Acacia Research Corporation (Nasdaq: ACTG) (Acacia or the Company), which acquires and operates businesses across the industrial, energy and technology sectors, today reported financial results for...

Acacia Research to Release Third Quarter 2025 Financial Results on November 5, 2025

Acacia Research Corporation (NASDAQ: ACTG) (Acacia or the Company), which acquires and operates businesses across the industrial, energy and technology sectors, announced today that it will release...

Acacia Research Corp. focuses on acquiring and operating businesses across the industrial, energy, and mature technology sectors where it believes it can leverage its expertise, significant capital base, and deep industry relationships to drive value. It operates through the following business segments: Intellectual Property Operations, Industrial Operations and Energy Operations. The Intellectual Property Operations segment invests in IP and related absolute return assets and engages in the licensing and enforcement of patented technologies. The Industrial Operations segment generates operating income by designing and manufacturing printers and consumable products for various industrial printing applications. The Energy Operations segment engages in the acquisition, exploration, development, and production of oil and natural gas resources located in Roberts and Hemphill Counties in Texas. The company was founded by Robert Bruce Stewart on January 25, 1993 and is headquartered in New York, NY.

Fiscal Period	Estimated	Reported	Surprise	Result
Q4 '25	-$0.14	--	--	N/A
Q3 '25	-$0.14	-$0.01	92.86%	BEAT
Q2 '25	-$0.05	-$0.06	-20.00%	MISSED
Q1 '25	-$0.05	$0.34	780.00%	BEAT
Q4 '24	-$0.07	-$0.07	--	EXPECTED

ACTG
Acacia Research Corp

Feed

News

Sentiment

Earnings

Fundamentals

Info

Upcoming Earnings: Q4 '25

Historical Earnings

Latest ACTG News

ACTGAcacia Research Corp